Last Posted: Feb 11, 2019
- Genomics and neurodegenerative disease
PHG Foundation infographic, February 2019 - Beyond medical actionability: Public perceptions of important actions in response to hypothetical genetic testing results.
Seiffert David J et al. Journal of genetic counseling 2019 Feb - A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
Porter Tenielle et al. Frontiers in aging neuroscience 2018 10423 - Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
IE Jansen et al, Nature Genetics, January 7, 2019 - Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci.
Witoelar Aree et al. Scientific reports 2018 Dec 8(1) 18088 - Radiogenomics for Precision Medicine With A Big Data Analytics Perspective.
Panayides Andreas S et al. IEEE journal of biomedical and health informatics 2018 Dec - APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease.
El Shamieh Said et al. Personalized medicine 2018 - Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
Bates Mary et al. IEEE pulse 9(6) 11-14 - Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypes
D Yan et al, BiorxIV preprints, November 12, 2018 - Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe Victoria S et al. Journal of neural transmission (Vienna, Austria : 1996) 2018 Oct
.png)
No hay comentarios:
Publicar un comentario